• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3A 站淋巴结清扫术不能提高可手术的右侧非小细胞肺癌患者的长期生存率:一项倾向评分匹配研究。

Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.

机构信息

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou City, Guangdong Province, China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou City, Guangdong Province, China.

出版信息

Thorac Cancer. 2022 Aug;13(15):2106-2116. doi: 10.1111/1759-7714.14456. Epub 2022 Jun 15.

DOI:10.1111/1759-7714.14456
PMID:35702992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346165/
Abstract

BACKGROUND

To investigate the impact of station 3A lymph node dissection (LND) on overall survival (OS) and disease-free survival (DFS) in completely resected right-side non-small-cell lung cancer (NSCLC) patients.

METHODS

A total of 1661 cases with completely resected right-side NSCLC were included. Propensity score matching (PSM) was performed to minimize selection bias, and a logistic regression model was conducted to investigate the risk factors associated with station 3A lymph node metastasis (LNM). The Kaplan-Meier method and Cox proportional hazards model were used to evaluate the impact of station 3A LND on survival.

RESULTS

For the entire cohort, 503 patients (30.3%) underwent station 3A LND. Of those, 11.3% (57/503) presented station 3A LNM. Univariate and multivariate logistic analyses showed that station 10 LNM, tumor location, and the number of resected lymph nodes were independent risk factors associated with station 3A LNM. Before PSM, patients with station 3A LND had worse 5-year OS (p = 0.002) and DFS (p = 0.011), and more drainage on postoperative day 1 (p = 0.041) than those without. After PSM, however, station 3A LND was not associated with the 5-year OS (65.7% vs. 63.6%, p = 0.432) or DFS (57.4% vs. 56.0%, p = 0.437). The multivariate analysis further confirmed that station 3A LND was not a prognostic factor (OS, p = 0.361; DFS, p = 0.447).

CONCLUSIONS

Station 3A LND could not improve long-term outcomes and it was unnecessary to dissect station 3A lymph nodes during surgery of right-side NSCLC.

摘要

背景

探讨完全切除的右侧非小细胞肺癌(NSCLC)患者的 3A 站淋巴结清扫术(LND)对总生存(OS)和无病生存(DFS)的影响。

方法

共纳入 1661 例完全切除的右侧 NSCLC 患者。采用倾向评分匹配(PSM)以最小化选择偏倚,并进行逻辑回归模型以探讨与 3A 站淋巴结转移(LNM)相关的危险因素。采用 Kaplan-Meier 方法和 Cox 比例风险模型评估 3A 站 LND 对生存的影响。

结果

对于整个队列,503 例患者(30.3%)接受了 3A 站 LND。其中,11.3%(57/503)存在 3A 站 LNM。单因素和多因素逻辑分析表明,10 站 LNM、肿瘤位置和切除的淋巴结数量是与 3A 站 LNM 相关的独立危险因素。在 PSM 之前,接受 3A 站 LND 的患者 5 年 OS(p=0.002)和 DFS(p=0.011)较差,术后第 1 天引流更多(p=0.041)。然而,PSM 后,3A 站 LND 与 5 年 OS(65.7% vs. 63.6%,p=0.432)或 DFS(57.4% vs. 56.0%,p=0.437)无关。多因素分析进一步证实,3A 站 LND 不是预后因素(OS,p=0.361;DFS,p=0.447)。

结论

3A 站 LND 不能改善长期预后,右侧 NSCLC 手术时无需解剖 3A 站淋巴结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/da5813839c4b/TCA-13-2106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/da5813839c4b/TCA-13-2106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/689c/9346165/f2f4b68c9063/TCA-13-2106-g001.jpg

相似文献

1
Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.3A 站淋巴结清扫术不能提高可手术的右侧非小细胞肺癌患者的长期生存率:一项倾向评分匹配研究。
Thorac Cancer. 2022 Aug;13(15):2106-2116. doi: 10.1111/1759-7714.14456. Epub 2022 Jun 15.
2
Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.右侧非小细胞肺癌患者第 3A 站淋巴结清扫的临床意义:回顾性倾向评分匹配分析。
Ann Surg Oncol. 2021 Jan;28(1):194-202. doi: 10.1245/s10434-020-08786-y. Epub 2020 Jul 7.
3
Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.L4 淋巴结清扫对左侧可手术非小细胞肺癌长期生存的影响:一项倾向评分匹配研究
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1181-1188. doi: 10.1093/ejcts/ezaa008.
4
The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.4L 站淋巴结清扫对非小细胞肺癌近期和远期结局的影响。
Lung Cancer. 2022 Aug;170:141-147. doi: 10.1016/j.lungcan.2022.06.018. Epub 2022 Jun 29.
5
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.肝内胆管癌准确的淋巴结分期需要充分的淋巴结清扫: 一项基于人群的研究。
Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16.
6
Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.3A 组纵隔淋巴结对非小细胞肺癌的预后作用
Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):447-54. doi: 10.1093/icvts/ivt265. Epub 2013 Jun 19.
7
The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.4L 淋巴结清扫术对左侧可手术非小细胞肺癌预后价值的荟萃分析。
Updates Surg. 2024 Jan;76(1):23-32. doi: 10.1007/s13304-023-01694-2. Epub 2023 Nov 8.
8
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.右原发性非小细胞肺癌患者 4R 淋巴结清扫的预后意义。
World J Surg Oncol. 2022 Jul 1;20(1):222. doi: 10.1186/s12957-022-02689-w.
9
Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.4L 淋巴结解剖在左侧非小细胞肺癌中的应用:一项荟萃分析。
ANZ J Surg. 2021 Nov;91(11):E696-E702. doi: 10.1111/ans.17131. Epub 2021 Aug 17.
10
Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.肺段特异性淋巴结清扫术联合术中冷冻切片分析在临床Ⅰ期非小细胞肺癌中的应用:一项倾向评分匹配验证研究。
Gen Thorac Cardiovasc Surg. 2022 Nov;70(11):977-984. doi: 10.1007/s11748-022-01827-1. Epub 2022 May 11.

引用本文的文献

1
PROX1 Expression in Resected Non-Small Cell Lung Cancer: Immunohistochemical Profile and Clinicopathological Correlates.PROX1在切除的非小细胞肺癌中的表达:免疫组织化学特征及临床病理相关性
Med Sci (Basel). 2025 Aug 17;13(3):140. doi: 10.3390/medsci13030140.
2
Impact of lymph node evaluation standard in patients undergoing lung resection for clinical stage IA pulmonary adenocarcinoma and squamous cell carcinoma.淋巴结评估标准对临床IA期肺腺癌和肺鳞癌患者肺切除手术的影响。
J Thorac Dis. 2024 Nov 30;16(11):7663-7674. doi: 10.21037/jtd-24-971. Epub 2024 Nov 11.
3
Application of tissue pneumoperitoneum technique around lymph nodes in thoracoscopic lung cancer resection.

本文引用的文献

1
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.NCCN 指南解读:非小细胞肺癌,第 2.2021 版。
J Natl Compr Canc Netw. 2021 Mar 2;19(3):254-266. doi: 10.6004/jnccn.2021.0013.
2
Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.右侧非小细胞肺癌患者第 3A 站淋巴结清扫的临床意义:回顾性倾向评分匹配分析。
Ann Surg Oncol. 2021 Jan;28(1):194-202. doi: 10.1245/s10434-020-08786-y. Epub 2020 Jul 7.
3
Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
组织气腹技术在胸腔镜肺癌切除术中淋巴结周围的应用
Front Oncol. 2024 Aug 26;14:1443088. doi: 10.3389/fonc.2024.1443088. eCollection 2024.
4
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.肿瘤转移的机制洞察与治疗干预:最新进展与展望
Signal Transduct Target Ther. 2024 Aug 2;9(1):192. doi: 10.1038/s41392-024-01885-2.
L4 淋巴结清扫对左侧可手术非小细胞肺癌长期生存的影响:一项倾向评分匹配研究
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1181-1188. doi: 10.1093/ejcts/ezaa008.
4
The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 cases.3cm 或以下非小细胞肺癌患者纵隔淋巴结转移的发生率、分布及其对生存的影响:来自 2292 例患者的数据。
Eur J Cardiothorac Surg. 2019 Jul 1;56(1):159-166. doi: 10.1093/ejcts/ezy479.
5
Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.非小细胞肺癌中叶特异性纵隔淋巴结转移的发生率和分布:来自 4511 例切除病例的数据。
Ann Surg Oncol. 2018 Oct;25(11):3300-3307. doi: 10.1245/s10434-018-6394-9. Epub 2018 Aug 6.
6
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期和局部晚期非小细胞肺癌(NSCLC):ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
7
Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.基于临床I期非小细胞肺癌肺叶切除术手术方式的长期生存情况:机器人手术、电视辅助胸腔镜手术和开胸肺叶切除术的比较
Ann Surg. 2017 Feb;265(2):431-437. doi: 10.1097/SLA.0000000000001708.
8
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.检查的淋巴结数量对切除的非小细胞肺癌精确分期及长期生存的影响:一项基于美国监测、流行病学和最终结果(SEER)数据库及中国多机构登记处的人群研究
J Clin Oncol. 2017 Apr 10;35(11):1162-1170. doi: 10.1200/JCO.2016.67.5140. Epub 2016 Dec 28.
9
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.IASLC 肺癌分期项目:对即将发布的(第八版)肺癌 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.
10
Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal.肺癌的淋巴引流具有肺叶特异性吗?一项外科评估。
Eur J Cardiothorac Surg. 2015 Mar;47(3):543-9. doi: 10.1093/ejcts/ezu226. Epub 2014 May 29.